105 related articles for article (PubMed ID: 2565391)
1. Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay.
Preziosi P; Martire M; Navarra P; Pistritto G; Vacca M
J Pharmacol Exp Ther; 1989 Apr; 249(1):256-63. PubMed ID: 2565391
[TBL] [Abstract][Full Text] [Related]
2. Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus.
Galzin AM; Moret C; Langer SZ
J Pharmacol Exp Ther; 1984 Mar; 228(3):725-32. PubMed ID: 6323679
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
Mongeau R; de Montigny C; Blier P
J Pharmacol Exp Ther; 1994 Jun; 269(3):1152-9. PubMed ID: 7912278
[TBL] [Abstract][Full Text] [Related]
4. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenoceptor-mediated inhibition of prolactin release in suckling- or fenfluramine-induced hyperprolactinemia.
Navarra P; Eechaute W; Preziosi P; Lacroix E
Horm Metab Res; 1991 May; 23(5):213-7. PubMed ID: 1678730
[TBL] [Abstract][Full Text] [Related]
6. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.
Vizi ES; Harsing LG; Gaal J; Kapocsi J; Bernath S; Somogyi GT
J Pharmacol Exp Ther; 1986 Aug; 238(2):701-6. PubMed ID: 2874217
[TBL] [Abstract][Full Text] [Related]
7. Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity.
Floch A; Advenier C
J Pharmacol; 1985; 16(3):291-7. PubMed ID: 2866275
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.
Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1985 May; 233(2):459-65. PubMed ID: 2987485
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
Dennis T; L'Heureux R; Carter C; Scatton B
J Pharmacol Exp Ther; 1987 May; 241(2):642-9. PubMed ID: 3033221
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
Boyajian CL; Leslie FM
J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
[TBL] [Abstract][Full Text] [Related]
11. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
12. Idazoxan: a novel pharmacological tool for the study of alpha 2-adrenoceptors.
Dabiré H
J Pharmacol; 1986; 17(2):113-8. PubMed ID: 2875218
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.
Maura G; Bonanno G; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):410-6. PubMed ID: 1352383
[TBL] [Abstract][Full Text] [Related]
15. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
Dabiré H; Fournier B; Schmitt H
C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
[TBL] [Abstract][Full Text] [Related]
16. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
17. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
Langer SZ; Moret C
J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
[TBL] [Abstract][Full Text] [Related]
18. Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine.
Ignatowski TA; Chou RC; Spengler RN
J Neuroimmunol; 1996 Oct; 70(1):55-63. PubMed ID: 8862135
[TBL] [Abstract][Full Text] [Related]
19. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
